Editorial
doi: 10.1002/art.24720.
Anti-cyclic citrullinated peptide testing for the diagnosis of rheumatoid arthritis and the quest for improved sensitivity and predictive value
- PMID: 19644881
- DOI: 10.1002/art.24720
Item in Clipboard
Editorial
Anti-cyclic citrullinated peptide testing for the diagnosis of rheumatoid arthritis and the quest for improved sensitivity and predictive value
Arthritis Rheum.
2009 Aug.
No abstract available
Comment in
-
Somatic mutations and anti-mutated citrullinated vimentin antibodies in rheumatoid arthritis: comment on the editorial by Levesque et al.Arthritis Rheum. 2010 Jan;62(1):303-4. doi: 10.1002/art.27187. Arthritis Rheum. 2010. PMID: 20039399 Free PMC article. No abstract available.
Comment on
-
Value of anti-modified citrullinated vimentin and third-generation anti-cyclic citrullinated peptide compared with second-generation anti-cyclic citrullinated peptide and rheumatoid factor in predicting disease outcome in undifferentiated arthritis and rheumatoid arthritis.Arthritis Rheum. 2009 Aug;60(8):2232-41. doi: 10.1002/art.24716. Arthritis Rheum. 2009. PMID: 19644872
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
